Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Neuro-Ox-2018: Assessment of cerebral oxygenation under three clinically relevant conditions
2017-002776-83Phase 4Terminated
- Sponsor
- Bispebjerg and Frederiksberg Hospital
- Start
- Jul 2017
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 4, open-label trial of oxygen and phenylephrine in brain neoplasm (3 arms), sponsored by Bispebjerg and Frederiksberg Hospital. Primary endpoint: Changes in cerebral oxygenation. Started Jul 2017; status: terminated.
02
Drugs
oxygenphenylephrine
03
Conditions
brain neoplasm
Beyond the preview
Go deeper on 2017-002776-83.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2017-002776-83.